Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.

Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR.

Dement Geriatr Cogn Disord. 2005;20(2-3):120-32. Epub 2005 Jun 30.

PMID:
15990426
[PubMed - indexed for MEDLINE]
2.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001747. Review.

PMID:
16437436
[PubMed - indexed for MEDLINE]
3.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
[PubMed - indexed for MEDLINE]
4.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747.

PMID:
12137632
[PubMed - indexed for MEDLINE]
5.

Galantamine for Alzheimer's disease.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001747.

PMID:
15495017
[PubMed - indexed for MEDLINE]
6.

Galantamine for vascular cognitive impairment.

Craig D, Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD004746.

PMID:
16437493
[PubMed - indexed for MEDLINE]
7.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(1):CD001747. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD001747.

PMID:
11279727
[PubMed - indexed for MEDLINE]
8.

Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

Imbimbo BP.

CNS Drugs. 2001;15(5):375-90. Review.

PMID:
11475943
[PubMed - indexed for MEDLINE]
9.

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

Rogers SL.

Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. Review.

PMID:
9853200
[PubMed - indexed for MEDLINE]
10.

Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease.

Seltzer B.

Clin Interv Aging. 2010 Feb 2;5:1-6. Review.

PMID:
20169037
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients.

Potkin SG.

Int Psychogeriatr. 2002;14 Suppl 1:7-26. Review.

PMID:
12636178
[PubMed - indexed for MEDLINE]
12.

Galantamine: additional benefits to patients with Alzheimer's disease.

Lilienfeld S, Parys W.

Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:19-27. Review.

PMID:
10971048
[PubMed - indexed for MEDLINE]
13.

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.

Schneider LS, Dagerman KS, Higgins JP, McShane R.

Arch Neurol. 2011 Aug;68(8):991-8. doi: 10.1001/archneurol.2011.69. Epub 2011 Apr 11. Review.

PMID:
21482915
[PubMed - indexed for MEDLINE]
14.

Galantamine: a review of its use in Alzheimer's disease.

Scott LJ, Goa KL.

Drugs. 2000 Nov;60(5):1095-122. Review.

PMID:
11129124
[PubMed - indexed for MEDLINE]
15.

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.

Trinh NH, Hoblyn J, Mohanty S, Yaffe K.

JAMA. 2003 Jan 8;289(2):210-6. Review.

PMID:
12517232
[PubMed - indexed for MEDLINE]
16.

Galantamine: therapeutic effects beyond cognition.

Blesa R.

Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:28-34. Review.

PMID:
10971049
[PubMed - indexed for MEDLINE]
17.

Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*.

Nieoullon A, Bentué-Ferrer D, Bordet R, Tsolaki M, Förstl H.

Curr Med Res Opin. 2008 Dec;24(12):3357-67. doi: 10.1185/03007990802522397 . Review.

PMID:
19032118
[PubMed - indexed for MEDLINE]
18.

Intranasal administration of acetylcholinesterase inhibitors.

Costantino HR, Leonard AK, Brandt G, Johnson PH, Quay SC.

BMC Neurosci. 2008 Dec 10;9 Suppl 3:S6. doi: 10.1186/1471-2202-9-S3-S6. Review.

PMID:
19091003
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A novel subject synchronization clinical trial design for Alzheimer's disease.

Schultz T, Yang E, Farnum M, Lobanov V, Verbeeck R, Raghavan N, Samtani MN, Novak G, Shi Y, Narayan V, DiBernardo A.

J Alzheimers Dis. 2012;31(3):507-16. doi: 10.3233/JAD-2012-120286. Review.

PMID:
22614878
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk